A shrub, used by native Californian tribes to treat respiratory ailments, fever and headaches, contains a potent chemical which could help treat Alzheimer's disease, a study claims.
The medicinal powers of aspirin, digitalis, and the anti-malarial artemisinin all come from plants.
The research, published in the journal Redox Biology, shows a that the treatment for Alzheimer's disease may also be found in nature.
"Because age is a major risk factor, researchers are looking at ways to counter aging's effects on the brain," said Pamela Maher, a scientist at Salk Institute in the US.
"Our identification of sterubin as a potent neuroprotective component of a native California plant called Yerba santa (Eriodictyon californicum) is a promising step in that direction," Maher said.
Native California tribes, which dubbed the plant "holy herb" in Spanish, have long used Yerba santa for its medicinal properties.
Devotees brew its leaves to treat respiratory ailments, fever and headaches; and mash it into a poultice for wounds, sore muscles and rheumatism.
To identify natural compounds that might reverse neurological disease symptoms, Maher applied a screening technique used in drug discovery to a commercial library of 400 plant extracts with known pharmacological properties.
The lab had previously used this approach to identify other chemicals (called flavonoids) from plants that have anti-inflammatory and neuroprotective properties.
Through the screen, the lab identified a molecule called sterubin as Yerba santa's most active component.
The researchers tested sterubin and other plant extracts for their impact on energy depletion in mouse nerve cells, as well as other age-associated neurotoxicity and survival pathways directly related to the reduced energy metabolism, accumulation of misfolded, aggregated proteins and inflammation seen in Alzheimer's.
Sterubin had a potent anti-inflammatory impact on brain cells known as microglia. It was also an effective iron remover -- potentially beneficial because iron can contribute to nerve cell damage in aging and neurodegenerative diseases.
Overall, the compound was effective against multiple inducers of cell death in the nerve cells, according to Maher.
"This is a compound that was known but ignored. Not only did sterubin turn out to be much more active than the other flavonoids in Yerba santa in our assays, it appears as good as, if not better than, other flavonoids we have studied," she said.
Next, the lab plans to test sterubin in an animal model of Alzheimer's, then determine its drug-like characteristics and toxicity levels in animals.
With that data, Maher said, it might be possible to test the compound in humans, although it would be critical to use sterubin derived from plants grown under standardised, controlled conditions.
She said the team will likely generate synthetic derivatives of sterubin.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
